Table 2. Comparison of BAL Fluid Analysis of Patients With Sarcoidosis and Non-Sarcoidosis ILDsa,b.
| Variables | Sarcoidosis | NS ILD | P |
|---|---|---|---|
| No of subjects | 119 | 142 | |
| CD4/CD8 | 3.87 (3.76) | 0.88 (1.01) | < 0.001 |
| Lymphocyte, % | 20.6 (28.3) | 6.0 (13.7) | < 0.001 |
| Neutrophil, % | 11.2 (8.3) | 16.4 (22.8) | < 0.001 |
| CD3 + 103 + , % | 22.9 (22) | 31.6 (17.8) | 0.052 |
| CD3 + 16 + 56 + , % | 5.6 (4.7) | 8.02 (6.7) | 0.008 |
| CD4 + , % | 70 (23) | 28 (24.4) | < 0.001 |
| CD8 + , % | 15 (18.8) | 36 (27.7) | < 0.001 |
| CD16 + 56 + , % | 2.6 (2.6) | 4.4 (5.2) | 0.008 |
| CD4 + 103 + , % | 8.6 (7.2) | 7 (5.7) | 0.417 |
| CD8 + 103 + , % | 8.9 (14.1) | 21 (26.3) | < 0.001 |
| CD103 + , % | 21.2 (20.8) | 34.5 (29.7) | 0.001 |
| TCR γ delta, % | 2.05 (2.1) | 2.7 (3.9) | 0.020 |
aAbbreviations: NS ILD: Nonsarcoidosis interstitial lung diseases, TCR: T cell receptor.
bValues presented as median (min-max).